nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Alkylating Activity—Mitomycin—stomach cancer	0.806	1	CiPCiCtD
Melphalan—SLC22A3—Irinotecan—stomach cancer	0.0966	1	CbGbCtD
Melphalan—Chlorambucil—GSTP1—stomach cancer	0.00153	0.57	CrCbGaD
Melphalan—SLC7A5—hematopoietic system—stomach cancer	0.0013	0.108	CbGeAlD
Melphalan—SLC7A5—epithelium—stomach cancer	0.00119	0.099	CbGeAlD
Melphalan—SLC7A5—smooth muscle tissue—stomach cancer	0.00114	0.0954	CbGeAlD
Melphalan—SLC7A5—pancreas—stomach cancer	0.00106	0.0882	CbGeAlD
Melphalan—SLC7A5—lymphoid tissue—stomach cancer	0.000913	0.0763	CbGeAlD
Melphalan—SLC7A5—digestive system—stomach cancer	0.000902	0.0753	CbGeAlD
Melphalan—SLC7A5—bone marrow—stomach cancer	0.000831	0.0694	CbGeAlD
Melphalan—SLC22A3—hematopoietic system—stomach cancer	0.000805	0.0672	CbGeAlD
Melphalan—SLC7A5—endocrine gland—stomach cancer	0.000745	0.0622	CbGeAlD
Melphalan—SLC22A3—smooth muscle tissue—stomach cancer	0.000709	0.0592	CbGeAlD
Melphalan—Ibuprofen—THBD—stomach cancer	0.000675	0.252	CrCbGaD
Melphalan—SLC7A5—liver—stomach cancer	0.000672	0.0561	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—SERPINB2—stomach cancer	0.000549	0.0924	CbGpPWpGaD
Melphalan—SLC7A5—Basigin interactions—PPIA—stomach cancer	0.000548	0.0922	CbGpPWpGaD
Melphalan—SLC7A5—lymph node—stomach cancer	0.000515	0.043	CbGeAlD
Melphalan—SLC22A3—endocrine gland—stomach cancer	0.000462	0.0386	CbGeAlD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC1A2—stomach cancer	0.000432	0.0728	CbGpPWpGaD
Melphalan—SLC22A3—liver—stomach cancer	0.000417	0.0348	CbGeAlD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—AHR—stomach cancer	0.000353	0.0595	CbGpPWpGaD
Melphalan—SLC22A3—lymph node—stomach cancer	0.00032	0.0267	CbGeAlD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—ITGA5—stomach cancer	0.000255	0.0429	CbGpPWpGaD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—stomach cancer	0.000254	0.0429	CbGpPWpGaD
Melphalan—SLC7A5—Basigin interactions—CAV1—stomach cancer	0.000253	0.0427	CbGpPWpGaD
Melphalan—Ibuprofen—CXCL8—stomach cancer	0.000213	0.0794	CrCbGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—THBD—stomach cancer	0.000197	0.0331	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PPIA—stomach cancer	0.000182	0.0307	CbGpPWpGaD
Melphalan—Ibuprofen—PPARG—stomach cancer	0.000147	0.0549	CrCbGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—CD44—stomach cancer	0.000135	0.0227	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000133	0.0224	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000114	0.0191	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—CDKN1B—stomach cancer	0.000102	0.0172	CbGpPWpGaD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—FYN—stomach cancer	0.000101	0.017	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL1B—stomach cancer	0.0001	0.0169	CbGpPWpGaD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—JUN—stomach cancer	9.7e-05	0.0163	CbGpPWpGaD
Melphalan—Urinary tract disorder—Capecitabine—stomach cancer	9.41e-05	0.00122	CcSEcCtD
Melphalan—Connective tissue disorder—Capecitabine—stomach cancer	9.36e-05	0.00122	CcSEcCtD
Melphalan—Urethral disorder—Capecitabine—stomach cancer	9.34e-05	0.00121	CcSEcCtD
Melphalan—Anorexia—Fluorouracil—stomach cancer	9.23e-05	0.0012	CcSEcCtD
Melphalan—Flushing—Docetaxel—stomach cancer	9.13e-05	0.00119	CcSEcCtD
Melphalan—Cardiac arrest—Epirubicin—stomach cancer	9.12e-05	0.00118	CcSEcCtD
Melphalan—Paraesthesia—Irinotecan—stomach cancer	9.08e-05	0.00118	CcSEcCtD
Melphalan—Hypotension—Fluorouracil—stomach cancer	9.05e-05	0.00118	CcSEcCtD
Melphalan—Dyspnoea—Irinotecan—stomach cancer	9.01e-05	0.00117	CcSEcCtD
Melphalan—Hyponatraemia—Doxorubicin—stomach cancer	8.91e-05	0.00116	CcSEcCtD
Melphalan—Dyspepsia—Irinotecan—stomach cancer	8.9e-05	0.00116	CcSEcCtD
Melphalan—Immune system disorder—Docetaxel—stomach cancer	8.89e-05	0.00115	CcSEcCtD
Melphalan—Mediastinal disorder—Docetaxel—stomach cancer	8.87e-05	0.00115	CcSEcCtD
Melphalan—Liver function test abnormal—Epirubicin—stomach cancer	8.85e-05	0.00115	CcSEcCtD
Melphalan—Flushing—Capecitabine—stomach cancer	8.84e-05	0.00115	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Fluorouracil—stomach cancer	8.82e-05	0.00115	CcSEcCtD
Melphalan—Decreased appetite—Irinotecan—stomach cancer	8.79e-05	0.00114	CcSEcCtD
Melphalan—Arrhythmia—Docetaxel—stomach cancer	8.79e-05	0.00114	CcSEcCtD
Melphalan—Gastrointestinal disorder—Irinotecan—stomach cancer	8.73e-05	0.00113	CcSEcCtD
Melphalan—Fatigue—Irinotecan—stomach cancer	8.72e-05	0.00113	CcSEcCtD
Melphalan—Paraesthesia—Fluorouracil—stomach cancer	8.69e-05	0.00113	CcSEcCtD
Melphalan—Alopecia—Docetaxel—stomach cancer	8.69e-05	0.00113	CcSEcCtD
Melphalan—Pain—Irinotecan—stomach cancer	8.65e-05	0.00112	CcSEcCtD
Melphalan—Dyspnoea—Fluorouracil—stomach cancer	8.63e-05	0.00112	CcSEcCtD
Melphalan—Immune system disorder—Capecitabine—stomach cancer	8.6e-05	0.00112	CcSEcCtD
Melphalan—Mediastinal disorder—Capecitabine—stomach cancer	8.58e-05	0.00111	CcSEcCtD
Melphalan—Dyspepsia—Fluorouracil—stomach cancer	8.52e-05	0.00111	CcSEcCtD
Melphalan—Arrhythmia—Capecitabine—stomach cancer	8.51e-05	0.0011	CcSEcCtD
Melphalan—Cardiac arrest—Doxorubicin—stomach cancer	8.44e-05	0.0011	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—CAV1—stomach cancer	8.43e-05	0.0142	CbGpPWpGaD
Melphalan—Decreased appetite—Fluorouracil—stomach cancer	8.42e-05	0.00109	CcSEcCtD
Melphalan—Alopecia—Capecitabine—stomach cancer	8.42e-05	0.00109	CcSEcCtD
Melphalan—Pancytopenia—Methotrexate—stomach cancer	8.41e-05	0.00109	CcSEcCtD
Melphalan—Gastrointestinal disorder—Fluorouracil—stomach cancer	8.36e-05	0.00109	CcSEcCtD
Melphalan—Neutropenia—Methotrexate—stomach cancer	8.28e-05	0.00108	CcSEcCtD
Melphalan—Pain—Fluorouracil—stomach cancer	8.28e-05	0.00108	CcSEcCtD
Melphalan—Liver function test abnormal—Doxorubicin—stomach cancer	8.19e-05	0.00106	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—SERPINB2—stomach cancer	8.06e-05	0.0136	CbGpPWpGaD
Melphalan—Anaemia—Docetaxel—stomach cancer	7.91e-05	0.00103	CcSEcCtD
Melphalan—Pancytopenia—Epirubicin—stomach cancer	7.87e-05	0.00102	CcSEcCtD
Melphalan—Neutropenia—Epirubicin—stomach cancer	7.75e-05	0.00101	CcSEcCtD
Melphalan—Stomatitis—Methotrexate—stomach cancer	7.7e-05	0.001	CcSEcCtD
Melphalan—Urticaria—Fluorouracil—stomach cancer	7.69e-05	0.000999	CcSEcCtD
Melphalan—Leukopenia—Docetaxel—stomach cancer	7.67e-05	0.000995	CcSEcCtD
Melphalan—Anaemia—Capecitabine—stomach cancer	7.66e-05	0.000995	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	7.63e-05	0.0128	CbGpPWpGaD
Melphalan—Cough—Docetaxel—stomach cancer	7.47e-05	0.00097	CcSEcCtD
Melphalan—Hepatobiliary disease—Methotrexate—stomach cancer	7.47e-05	0.00097	CcSEcCtD
Melphalan—Hypersensitivity—Irinotecan—stomach cancer	7.45e-05	0.000967	CcSEcCtD
Melphalan—Leukopenia—Capecitabine—stomach cancer	7.42e-05	0.000964	CcSEcCtD
Melphalan—Convulsion—Docetaxel—stomach cancer	7.42e-05	0.000964	CcSEcCtD
Melphalan—Chest pain—Docetaxel—stomach cancer	7.29e-05	0.000947	CcSEcCtD
Melphalan—Myalgia—Docetaxel—stomach cancer	7.29e-05	0.000947	CcSEcCtD
Melphalan—Pancytopenia—Doxorubicin—stomach cancer	7.28e-05	0.000946	CcSEcCtD
Melphalan—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	7.26e-05	0.0122	CbGpPWpGaD
Melphalan—Asthenia—Irinotecan—stomach cancer	7.25e-05	0.000942	CcSEcCtD
Melphalan—Neuropathy peripheral—Epirubicin—stomach cancer	7.24e-05	0.000941	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	7.24e-05	0.00094	CcSEcCtD
Melphalan—Cough—Capecitabine—stomach cancer	7.23e-05	0.00094	CcSEcCtD
Melphalan—Jaundice—Epirubicin—stomach cancer	7.2e-05	0.000936	CcSEcCtD
Melphalan—Stomatitis—Epirubicin—stomach cancer	7.2e-05	0.000936	CcSEcCtD
Melphalan—Neutropenia—Doxorubicin—stomach cancer	7.17e-05	0.000931	CcSEcCtD
Melphalan—Hypersensitivity—Fluorouracil—stomach cancer	7.13e-05	0.000926	CcSEcCtD
Melphalan—Haemoglobin—Methotrexate—stomach cancer	7.13e-05	0.000925	CcSEcCtD
Melphalan—Haemorrhage—Methotrexate—stomach cancer	7.09e-05	0.000921	CcSEcCtD
Melphalan—Hepatitis—Methotrexate—stomach cancer	7.09e-05	0.000921	CcSEcCtD
Melphalan—Chest pain—Capecitabine—stomach cancer	7.06e-05	0.000917	CcSEcCtD
Melphalan—Myalgia—Capecitabine—stomach cancer	7.06e-05	0.000917	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	7.01e-05	0.00091	CcSEcCtD
Melphalan—Urinary tract disorder—Methotrexate—stomach cancer	7e-05	0.000909	CcSEcCtD
Melphalan—Hepatobiliary disease—Epirubicin—stomach cancer	6.99e-05	0.000908	CcSEcCtD
Melphalan—Anaphylactic shock—Docetaxel—stomach cancer	6.99e-05	0.000908	CcSEcCtD
Melphalan—Oedema—Docetaxel—stomach cancer	6.99e-05	0.000908	CcSEcCtD
Melphalan—Urethral disorder—Methotrexate—stomach cancer	6.95e-05	0.000903	CcSEcCtD
Melphalan—Infection—Docetaxel—stomach cancer	6.94e-05	0.000902	CcSEcCtD
Melphalan—Diarrhoea—Irinotecan—stomach cancer	6.92e-05	0.000898	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—ITGA5—stomach cancer	6.91e-05	0.0116	CbGpPWpGaD
Melphalan—Pruritus—Fluorouracil—stomach cancer	6.85e-05	0.00089	CcSEcCtD
Melphalan—Thrombocytopenia—Docetaxel—stomach cancer	6.84e-05	0.000889	CcSEcCtD
Melphalan—Tachycardia—Docetaxel—stomach cancer	6.82e-05	0.000886	CcSEcCtD
Melphalan—Skin disorder—Docetaxel—stomach cancer	6.79e-05	0.000882	CcSEcCtD
Melphalan—Oedema—Capecitabine—stomach cancer	6.77e-05	0.000879	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—CLCN3—stomach cancer	6.76e-05	0.0114	CbGpPWpGaD
Melphalan—Infection—Capecitabine—stomach cancer	6.72e-05	0.000873	CcSEcCtD
Melphalan—Neuropathy peripheral—Doxorubicin—stomach cancer	6.7e-05	0.000871	CcSEcCtD
Melphalan—Haemoglobin—Epirubicin—stomach cancer	6.67e-05	0.000866	CcSEcCtD
Melphalan—Jaundice—Doxorubicin—stomach cancer	6.67e-05	0.000866	CcSEcCtD
Melphalan—Stomatitis—Doxorubicin—stomach cancer	6.67e-05	0.000866	CcSEcCtD
Melphalan—Anorexia—Docetaxel—stomach cancer	6.66e-05	0.000865	CcSEcCtD
Melphalan—Haemorrhage—Epirubicin—stomach cancer	6.63e-05	0.000862	CcSEcCtD
Melphalan—Hepatitis—Epirubicin—stomach cancer	6.63e-05	0.000862	CcSEcCtD
Melphalan—Diarrhoea—Fluorouracil—stomach cancer	6.63e-05	0.00086	CcSEcCtD
Melphalan—Thrombocytopenia—Capecitabine—stomach cancer	6.63e-05	0.00086	CcSEcCtD
Melphalan—Tachycardia—Capecitabine—stomach cancer	6.6e-05	0.000858	CcSEcCtD
Melphalan—Skin disorder—Capecitabine—stomach cancer	6.57e-05	0.000854	CcSEcCtD
Melphalan—Urinary tract disorder—Epirubicin—stomach cancer	6.55e-05	0.000851	CcSEcCtD
Melphalan—Hypotension—Docetaxel—stomach cancer	6.53e-05	0.000848	CcSEcCtD
Melphalan—Connective tissue disorder—Epirubicin—stomach cancer	6.52e-05	0.000847	CcSEcCtD
Melphalan—Urethral disorder—Epirubicin—stomach cancer	6.5e-05	0.000845	CcSEcCtD
Melphalan—Hepatobiliary disease—Doxorubicin—stomach cancer	6.47e-05	0.00084	CcSEcCtD
Melphalan—Anorexia—Capecitabine—stomach cancer	6.45e-05	0.000838	CcSEcCtD
Melphalan—Vomiting—Irinotecan—stomach cancer	6.43e-05	0.000835	CcSEcCtD
Melphalan—Immune system disorder—Methotrexate—stomach cancer	6.4e-05	0.000832	CcSEcCtD
Melphalan—Mediastinal disorder—Methotrexate—stomach cancer	6.39e-05	0.00083	CcSEcCtD
Melphalan—Rash—Irinotecan—stomach cancer	6.37e-05	0.000828	CcSEcCtD
Melphalan—Dermatitis—Irinotecan—stomach cancer	6.37e-05	0.000827	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Docetaxel—stomach cancer	6.37e-05	0.000827	CcSEcCtD
Melphalan—Hypotension—Capecitabine—stomach cancer	6.32e-05	0.000821	CcSEcCtD
Melphalan—Paraesthesia—Docetaxel—stomach cancer	6.28e-05	0.000815	CcSEcCtD
Melphalan—Alopecia—Methotrexate—stomach cancer	6.27e-05	0.000814	CcSEcCtD
Melphalan—Dyspnoea—Docetaxel—stomach cancer	6.23e-05	0.000809	CcSEcCtD
Melphalan—Ibuprofen—PTGS2—stomach cancer	6.22e-05	0.0232	CrCbGaD
Melphalan—Haemoglobin—Doxorubicin—stomach cancer	6.17e-05	0.000801	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Capecitabine—stomach cancer	6.16e-05	0.000801	CcSEcCtD
Melphalan—Flushing—Epirubicin—stomach cancer	6.16e-05	0.0008	CcSEcCtD
Melphalan—Vomiting—Fluorouracil—stomach cancer	6.16e-05	0.0008	CcSEcCtD
Melphalan—Dyspepsia—Docetaxel—stomach cancer	6.15e-05	0.000799	CcSEcCtD
Melphalan—Hepatitis—Doxorubicin—stomach cancer	6.14e-05	0.000797	CcSEcCtD
Melphalan—Haemorrhage—Doxorubicin—stomach cancer	6.14e-05	0.000797	CcSEcCtD
Melphalan—Rash—Fluorouracil—stomach cancer	6.11e-05	0.000793	CcSEcCtD
Melphalan—Dermatitis—Fluorouracil—stomach cancer	6.1e-05	0.000792	CcSEcCtD
Melphalan—Paraesthesia—Capecitabine—stomach cancer	6.08e-05	0.000789	CcSEcCtD
Melphalan—Decreased appetite—Docetaxel—stomach cancer	6.08e-05	0.000789	CcSEcCtD
Melphalan—Urinary tract disorder—Doxorubicin—stomach cancer	6.06e-05	0.000787	CcSEcCtD
Melphalan—Gastrointestinal disorder—Docetaxel—stomach cancer	6.03e-05	0.000784	CcSEcCtD
Melphalan—Connective tissue disorder—Doxorubicin—stomach cancer	6.03e-05	0.000783	CcSEcCtD
Melphalan—Dyspnoea—Capecitabine—stomach cancer	6.03e-05	0.000783	CcSEcCtD
Melphalan—Fatigue—Docetaxel—stomach cancer	6.03e-05	0.000782	CcSEcCtD
Melphalan—Urethral disorder—Doxorubicin—stomach cancer	6.02e-05	0.000782	CcSEcCtD
Melphalan—Nausea—Irinotecan—stomach cancer	6.01e-05	0.00078	CcSEcCtD
Melphalan—Immune system disorder—Epirubicin—stomach cancer	5.99e-05	0.000778	CcSEcCtD
Melphalan—Mediastinal disorder—Epirubicin—stomach cancer	5.98e-05	0.000777	CcSEcCtD
Melphalan—Pain—Docetaxel—stomach cancer	5.98e-05	0.000776	CcSEcCtD
Melphalan—Dyspepsia—Capecitabine—stomach cancer	5.96e-05	0.000774	CcSEcCtD
Melphalan—Arrhythmia—Epirubicin—stomach cancer	5.93e-05	0.00077	CcSEcCtD
Melphalan—Decreased appetite—Capecitabine—stomach cancer	5.88e-05	0.000764	CcSEcCtD
Melphalan—Alopecia—Epirubicin—stomach cancer	5.86e-05	0.000761	CcSEcCtD
Melphalan—Gastrointestinal disorder—Capecitabine—stomach cancer	5.84e-05	0.000759	CcSEcCtD
Melphalan—Fatigue—Capecitabine—stomach cancer	5.83e-05	0.000758	CcSEcCtD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	5.79e-05	0.00975	CbGpPWpGaD
Melphalan—Pain—Capecitabine—stomach cancer	5.79e-05	0.000751	CcSEcCtD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC1A2—stomach cancer	5.78e-05	0.00973	CbGpPWpGaD
Melphalan—Nausea—Fluorouracil—stomach cancer	5.75e-05	0.000747	CcSEcCtD
Melphalan—Anaemia—Methotrexate—stomach cancer	5.7e-05	0.000741	CcSEcCtD
Melphalan—Flushing—Doxorubicin—stomach cancer	5.7e-05	0.00074	CcSEcCtD
Melphalan—Immune system disorder—Doxorubicin—stomach cancer	5.55e-05	0.00072	CcSEcCtD
Melphalan—Ibuprofen—ALB—stomach cancer	5.54e-05	0.0206	CrCbGaD
Melphalan—Mediastinal disorder—Doxorubicin—stomach cancer	5.53e-05	0.000719	CcSEcCtD
Melphalan—Leukopenia—Methotrexate—stomach cancer	5.52e-05	0.000717	CcSEcCtD
Melphalan—Arrhythmia—Doxorubicin—stomach cancer	5.48e-05	0.000712	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—FGG—stomach cancer	5.44e-05	0.00916	CbGpPWpGaD
Melphalan—Alopecia—Doxorubicin—stomach cancer	5.42e-05	0.000705	CcSEcCtD
Melphalan—Cough—Methotrexate—stomach cancer	5.39e-05	0.000699	CcSEcCtD
Melphalan—Urticaria—Capecitabine—stomach cancer	5.38e-05	0.000698	CcSEcCtD
Melphalan—Convulsion—Methotrexate—stomach cancer	5.35e-05	0.000694	CcSEcCtD
Melphalan—Anaemia—Epirubicin—stomach cancer	5.34e-05	0.000693	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—THBD—stomach cancer	5.34e-05	0.00899	CbGpPWpGaD
Melphalan—Myalgia—Methotrexate—stomach cancer	5.25e-05	0.000682	CcSEcCtD
Melphalan—Chest pain—Methotrexate—stomach cancer	5.25e-05	0.000682	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	5.22e-05	0.000678	CcSEcCtD
Melphalan—Leukopenia—Epirubicin—stomach cancer	5.17e-05	0.000671	CcSEcCtD
Melphalan—Hypersensitivity—Docetaxel—stomach cancer	5.15e-05	0.000669	CcSEcCtD
Melphalan—Cough—Epirubicin—stomach cancer	5.04e-05	0.000655	CcSEcCtD
Melphalan—Anaphylactic shock—Methotrexate—stomach cancer	5.04e-05	0.000654	CcSEcCtD
Melphalan—Asthenia—Docetaxel—stomach cancer	5.01e-05	0.000651	CcSEcCtD
Melphalan—Convulsion—Epirubicin—stomach cancer	5e-05	0.00065	CcSEcCtD
Melphalan—Infection—Methotrexate—stomach cancer	5e-05	0.00065	CcSEcCtD
Melphalan—Hypersensitivity—Capecitabine—stomach cancer	4.99e-05	0.000647	CcSEcCtD
Melphalan—Pruritus—Docetaxel—stomach cancer	4.94e-05	0.000642	CcSEcCtD
Melphalan—Anaemia—Doxorubicin—stomach cancer	4.94e-05	0.000641	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PPIA—stomach cancer	4.94e-05	0.00832	CbGpPWpGaD
Melphalan—Thrombocytopenia—Methotrexate—stomach cancer	4.93e-05	0.00064	CcSEcCtD
Melphalan—Chest pain—Epirubicin—stomach cancer	4.92e-05	0.000639	CcSEcCtD
Melphalan—Myalgia—Epirubicin—stomach cancer	4.92e-05	0.000639	CcSEcCtD
Melphalan—Skin disorder—Methotrexate—stomach cancer	4.89e-05	0.000635	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	4.88e-05	0.000634	CcSEcCtD
Melphalan—Asthenia—Capecitabine—stomach cancer	4.85e-05	0.00063	CcSEcCtD
Melphalan—Anorexia—Methotrexate—stomach cancer	4.8e-05	0.000624	CcSEcCtD
Melphalan—Pruritus—Capecitabine—stomach cancer	4.79e-05	0.000622	CcSEcCtD
Melphalan—Leukopenia—Doxorubicin—stomach cancer	4.78e-05	0.000621	CcSEcCtD
Melphalan—Diarrhoea—Docetaxel—stomach cancer	4.78e-05	0.000621	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—SERPINA1—stomach cancer	4.76e-05	0.00801	CbGpPWpGaD
Melphalan—Anaphylactic shock—Epirubicin—stomach cancer	4.71e-05	0.000612	CcSEcCtD
Melphalan—Oedema—Epirubicin—stomach cancer	4.71e-05	0.000612	CcSEcCtD
Melphalan—Hypotension—Methotrexate—stomach cancer	4.71e-05	0.000611	CcSEcCtD
Melphalan—Infection—Epirubicin—stomach cancer	4.68e-05	0.000608	CcSEcCtD
Melphalan—Cough—Doxorubicin—stomach cancer	4.66e-05	0.000606	CcSEcCtD
Melphalan—Convulsion—Doxorubicin—stomach cancer	4.63e-05	0.000601	CcSEcCtD
Melphalan—Diarrhoea—Capecitabine—stomach cancer	4.63e-05	0.000601	CcSEcCtD
Melphalan—Thrombocytopenia—Epirubicin—stomach cancer	4.62e-05	0.000599	CcSEcCtD
Melphalan—Tachycardia—Epirubicin—stomach cancer	4.6e-05	0.000597	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.59e-05	0.000596	CcSEcCtD
Melphalan—Skin disorder—Epirubicin—stomach cancer	4.58e-05	0.000595	CcSEcCtD
Melphalan—Myalgia—Doxorubicin—stomach cancer	4.55e-05	0.000591	CcSEcCtD
Melphalan—Chest pain—Doxorubicin—stomach cancer	4.55e-05	0.000591	CcSEcCtD
Melphalan—Paraesthesia—Methotrexate—stomach cancer	4.52e-05	0.000587	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	4.52e-05	0.000587	CcSEcCtD
Melphalan—Anorexia—Epirubicin—stomach cancer	4.49e-05	0.000584	CcSEcCtD
Melphalan—Dyspnoea—Methotrexate—stomach cancer	4.49e-05	0.000583	CcSEcCtD
Melphalan—Vomiting—Docetaxel—stomach cancer	4.44e-05	0.000577	CcSEcCtD
Melphalan—Dyspepsia—Methotrexate—stomach cancer	4.43e-05	0.000576	CcSEcCtD
Melphalan—Rash—Docetaxel—stomach cancer	4.41e-05	0.000572	CcSEcCtD
Melphalan—Hypotension—Epirubicin—stomach cancer	4.4e-05	0.000572	CcSEcCtD
Melphalan—Dermatitis—Docetaxel—stomach cancer	4.4e-05	0.000572	CcSEcCtD
Melphalan—Decreased appetite—Methotrexate—stomach cancer	4.38e-05	0.000569	CcSEcCtD
Melphalan—Anaphylactic shock—Doxorubicin—stomach cancer	4.36e-05	0.000566	CcSEcCtD
Melphalan—Oedema—Doxorubicin—stomach cancer	4.36e-05	0.000566	CcSEcCtD
Melphalan—Gastrointestinal disorder—Methotrexate—stomach cancer	4.35e-05	0.000565	CcSEcCtD
Melphalan—Fatigue—Methotrexate—stomach cancer	4.34e-05	0.000564	CcSEcCtD
Melphalan—Infection—Doxorubicin—stomach cancer	4.33e-05	0.000563	CcSEcCtD
Melphalan—Pain—Methotrexate—stomach cancer	4.31e-05	0.000559	CcSEcCtD
Melphalan—Vomiting—Capecitabine—stomach cancer	4.3e-05	0.000559	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—F2R—stomach cancer	4.3e-05	0.00724	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SPARC—stomach cancer	4.3e-05	0.00724	CbGpPWpGaD
Melphalan—Musculoskeletal discomfort—Epirubicin—stomach cancer	4.29e-05	0.000558	CcSEcCtD
Melphalan—Thrombocytopenia—Doxorubicin—stomach cancer	4.27e-05	0.000555	CcSEcCtD
Melphalan—Rash—Capecitabine—stomach cancer	4.27e-05	0.000554	CcSEcCtD
Melphalan—Dermatitis—Capecitabine—stomach cancer	4.26e-05	0.000554	CcSEcCtD
Melphalan—Tachycardia—Doxorubicin—stomach cancer	4.26e-05	0.000553	CcSEcCtD
Melphalan—Skin disorder—Doxorubicin—stomach cancer	4.24e-05	0.00055	CcSEcCtD
Melphalan—Paraesthesia—Epirubicin—stomach cancer	4.23e-05	0.00055	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—IRF1—stomach cancer	4.21e-05	0.00709	CbGpPWpGaD
Melphalan—Dyspnoea—Epirubicin—stomach cancer	4.2e-05	0.000546	CcSEcCtD
Melphalan—Anorexia—Doxorubicin—stomach cancer	4.16e-05	0.00054	CcSEcCtD
Melphalan—Nausea—Docetaxel—stomach cancer	4.15e-05	0.000539	CcSEcCtD
Melphalan—Dyspepsia—Epirubicin—stomach cancer	4.15e-05	0.000539	CcSEcCtD
Melphalan—Decreased appetite—Epirubicin—stomach cancer	4.1e-05	0.000532	CcSEcCtD
Melphalan—Hypotension—Doxorubicin—stomach cancer	4.08e-05	0.000529	CcSEcCtD
Melphalan—Gastrointestinal disorder—Epirubicin—stomach cancer	4.07e-05	0.000529	CcSEcCtD
Melphalan—Fatigue—Epirubicin—stomach cancer	4.06e-05	0.000528	CcSEcCtD
Melphalan—Pain—Epirubicin—stomach cancer	4.03e-05	0.000523	CcSEcCtD
Melphalan—Nausea—Capecitabine—stomach cancer	4.02e-05	0.000522	CcSEcCtD
Melphalan—Urticaria—Methotrexate—stomach cancer	4e-05	0.00052	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	3.97e-05	0.000516	CcSEcCtD
Melphalan—Paraesthesia—Doxorubicin—stomach cancer	3.92e-05	0.000509	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—KRAS—stomach cancer	3.9e-05	0.00657	CbGpPWpGaD
Melphalan—Dyspnoea—Doxorubicin—stomach cancer	3.89e-05	0.000505	CcSEcCtD
Melphalan—Dyspepsia—Doxorubicin—stomach cancer	3.84e-05	0.000499	CcSEcCtD
Melphalan—Decreased appetite—Doxorubicin—stomach cancer	3.79e-05	0.000492	CcSEcCtD
Melphalan—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.77e-05	0.000489	CcSEcCtD
Melphalan—Fatigue—Doxorubicin—stomach cancer	3.76e-05	0.000488	CcSEcCtD
Melphalan—Urticaria—Epirubicin—stomach cancer	3.74e-05	0.000486	CcSEcCtD
Melphalan—Pain—Doxorubicin—stomach cancer	3.73e-05	0.000484	CcSEcCtD
Melphalan—Hypersensitivity—Methotrexate—stomach cancer	3.71e-05	0.000482	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—CD44—stomach cancer	3.66e-05	0.00616	CbGpPWpGaD
Melphalan—Asthenia—Methotrexate—stomach cancer	3.61e-05	0.000469	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—PIK3CA—stomach cancer	3.59e-05	0.00604	CbGpPWpGaD
Melphalan—Pruritus—Methotrexate—stomach cancer	3.56e-05	0.000463	CcSEcCtD
Melphalan—Hypersensitivity—Epirubicin—stomach cancer	3.47e-05	0.000451	CcSEcCtD
Melphalan—Urticaria—Doxorubicin—stomach cancer	3.46e-05	0.00045	CcSEcCtD
Melphalan—Diarrhoea—Methotrexate—stomach cancer	3.45e-05	0.000448	CcSEcCtD
Melphalan—Asthenia—Epirubicin—stomach cancer	3.38e-05	0.000439	CcSEcCtD
Melphalan—Pruritus—Epirubicin—stomach cancer	3.34e-05	0.000433	CcSEcCtD
Melphalan—SLC7A5—Cell surface interactions at the vascular wall—HRAS—stomach cancer	3.32e-05	0.00559	CbGpPWpGaD
Melphalan—Diarrhoea—Epirubicin—stomach cancer	3.23e-05	0.000419	CcSEcCtD
Melphalan—Hypersensitivity—Doxorubicin—stomach cancer	3.21e-05	0.000417	CcSEcCtD
Melphalan—Vomiting—Methotrexate—stomach cancer	3.2e-05	0.000416	CcSEcCtD
Melphalan—Rash—Methotrexate—stomach cancer	3.18e-05	0.000412	CcSEcCtD
Melphalan—Dermatitis—Methotrexate—stomach cancer	3.17e-05	0.000412	CcSEcCtD
Melphalan—SLC22A3—Metabolism—ACAD8—stomach cancer	3.17e-05	0.00533	CbGpPWpGaD
Melphalan—Asthenia—Doxorubicin—stomach cancer	3.13e-05	0.000406	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—PPP2R1A—stomach cancer	3.11e-05	0.00524	CbGpPWpGaD
Melphalan—Pruritus—Doxorubicin—stomach cancer	3.09e-05	0.000401	CcSEcCtD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—ALB—stomach cancer	3.08e-05	0.00518	CbGpPWpGaD
Melphalan—Vomiting—Epirubicin—stomach cancer	3e-05	0.000389	CcSEcCtD
Melphalan—Nausea—Methotrexate—stomach cancer	2.99e-05	0.000389	CcSEcCtD
Melphalan—Diarrhoea—Doxorubicin—stomach cancer	2.98e-05	0.000388	CcSEcCtD
Melphalan—Rash—Epirubicin—stomach cancer	2.97e-05	0.000386	CcSEcCtD
Melphalan—Dermatitis—Epirubicin—stomach cancer	2.97e-05	0.000386	CcSEcCtD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC1A2—stomach cancer	2.94e-05	0.00496	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GMPR2—stomach cancer	2.82e-05	0.00475	CbGpPWpGaD
Melphalan—Nausea—Epirubicin—stomach cancer	2.8e-05	0.000364	CcSEcCtD
Melphalan—Vomiting—Doxorubicin—stomach cancer	2.77e-05	0.00036	CcSEcCtD
Melphalan—Rash—Doxorubicin—stomach cancer	2.75e-05	0.000357	CcSEcCtD
Melphalan—Dermatitis—Doxorubicin—stomach cancer	2.75e-05	0.000357	CcSEcCtD
Melphalan—SLC7A5—Hemostasis—FYN—stomach cancer	2.74e-05	0.00462	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.6e-05	0.00439	CbGpPWpGaD
Melphalan—Nausea—Doxorubicin—stomach cancer	2.59e-05	0.000336	CcSEcCtD
Melphalan—SLC22A3—Metabolism—SUCLG1—stomach cancer	2.58e-05	0.00435	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—IDH3B—stomach cancer	2.58e-05	0.00435	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NDUFS1—stomach cancer	2.4e-05	0.00404	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NDUFV1—stomach cancer	2.4e-05	0.00404	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLAU—stomach cancer	2.34e-05	0.00394	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—CAV1—stomach cancer	2.29e-05	0.00385	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—APOA1—stomach cancer	2.28e-05	0.00384	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PRKCB—stomach cancer	2.17e-05	0.00366	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PGLS—stomach cancer	2.14e-05	0.0036	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—BLVRB—stomach cancer	2.14e-05	0.0036	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPAP2A—stomach cancer	2.04e-05	0.00344	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—APOA1—stomach cancer	1.97e-05	0.00332	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CA1—stomach cancer	1.82e-05	0.00306	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NDUFA2—stomach cancer	1.82e-05	0.00306	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—FBP1—stomach cancer	1.82e-05	0.00306	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CKB—stomach cancer	1.82e-05	0.00306	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—SERPINE1—stomach cancer	1.81e-05	0.00305	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—ALB—stomach cancer	1.81e-05	0.00304	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—RHOA—stomach cancer	1.75e-05	0.00294	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—NOS3—stomach cancer	1.73e-05	0.00291	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLIN2—stomach cancer	1.71e-05	0.00288	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CA2—stomach cancer	1.66e-05	0.0028	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NT5E—stomach cancer	1.62e-05	0.00273	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PGAM1—stomach cancer	1.62e-05	0.00273	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—ALB—stomach cancer	1.57e-05	0.00264	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—ALB—stomach cancer	1.56e-05	0.00263	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLCE1—stomach cancer	1.55e-05	0.0026	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALDH7A1—stomach cancer	1.55e-05	0.0026	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—UMPS—stomach cancer	1.48e-05	0.0025	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PDHA1—stomach cancer	1.38e-05	0.00232	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ECHS1—stomach cancer	1.38e-05	0.00232	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.33e-05	0.00223	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—TYMP—stomach cancer	1.3e-05	0.00218	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—FADS1—stomach cancer	1.3e-05	0.00218	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—VEGFA—stomach cancer	1.24e-05	0.0021	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SREBF2—stomach cancer	1.21e-05	0.00204	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—RORA—stomach cancer	1.2e-05	0.00202	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MAPK3—stomach cancer	1.18e-05	0.00198	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALDOB—stomach cancer	1.12e-05	0.00189	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—MAPK1—stomach cancer	1.12e-05	0.00189	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—KRAS—stomach cancer	1.06e-05	0.00178	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALOX5—stomach cancer	1.04e-05	0.00176	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—DPYD—stomach cancer	1.03e-05	0.00173	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—APOA1—stomach cancer	1.01e-05	0.00169	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PIK3CA—stomach cancer	9.72e-06	0.00164	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—TP53—stomach cancer	9.41e-06	0.00158	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTT1—stomach cancer	9.09e-06	0.00153	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—HRAS—stomach cancer	8.99e-06	0.00151	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CYP2A6—stomach cancer	8.98e-06	0.00151	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—AKR1C3—stomach cancer	8.74e-06	0.00147	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ENO1—stomach cancer	8.52e-06	0.00143	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—ALB—stomach cancer	7.96e-06	0.00134	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CD44—stomach cancer	7.55e-06	0.00127	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPP2R1A—stomach cancer	6.42e-06	0.00108	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTP1—stomach cancer	6.3e-06	0.00106	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—HMOX1—stomach cancer	6.21e-06	0.00105	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—TYMS—stomach cancer	5.86e-06	0.000986	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTM1—stomach cancer	5.79e-06	0.000975	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ERCC2—stomach cancer	5.44e-06	0.000917	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—MTHFR—stomach cancer	5.12e-06	0.000862	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CAV1—stomach cancer	4.72e-06	0.000795	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOA1—stomach cancer	4.71e-06	0.000793	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PPARG—stomach cancer	4.15e-06	0.000699	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—ALB—stomach cancer	3.73e-06	0.000628	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—NOS3—stomach cancer	3.57e-06	0.000601	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS2—stomach cancer	3.26e-06	0.00055	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PIK3CA—stomach cancer	2.01e-06	0.000338	CbGpPWpGaD
